[go: up one dir, main page]

MX2024013999A - Composicion nutricional que comprende gos y hmo - Google Patents

Composicion nutricional que comprende gos y hmo

Info

Publication number
MX2024013999A
MX2024013999A MX2024013999A MX2024013999A MX2024013999A MX 2024013999 A MX2024013999 A MX 2024013999A MX 2024013999 A MX2024013999 A MX 2024013999A MX 2024013999 A MX2024013999 A MX 2024013999A MX 2024013999 A MX2024013999 A MX 2024013999A
Authority
MX
Mexico
Prior art keywords
hmos
combination
gos
mixture
oligosaccharides
Prior art date
Application number
MX2024013999A
Other languages
English (en)
Inventor
Degonda Gabriela Bergonzelli
Laurent Ferrier
Ivana Jankovic
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2024013999A publication Critical patent/MX2024013999A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se relaciona con una combinación de galactooligosacáridos (GOS) y una mezcla de oligosacáridos de la leche humana (HMO), o composiciones nutricionales que comprenden la combinación. La combinación o composiciones son para usar en el tratamiento y/o prevención del estrés y/o un trastorno del estado de ánimo en un infante, niño pequeño y/o niño. La mezcla de HMO consiste o consiste esencialmente en 2'-fucosillactosa (2'FL) y difucosillactosa (DFL) o en lacto-N-tetraosa (LNT) y 6' sialillactosa (6'SL). La presente invención también se relaciona con el uso de una combinación de galactooligosacáridos (GOS) y una mezcla de oligosacáridos de la leche humana (HMO), o composiciones que comprenden la combinación, para tratar y/o prevenir el estrés y/o un trastorno del estado de animo en un infante, niño pequeño y/o niño, en donde la mezcla de HMO consiste o consiste esencialmente en 2'fucosillactosa (2'FL) y difucosillactosa (DFL) o en lacto-N-tetraosa (LNT) y 6' sialillactosa (6'SL).
MX2024013999A 2022-06-09 2024-11-12 Composicion nutricional que comprende gos y hmo MX2024013999A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22178116 2022-06-09
PCT/EP2023/063176 WO2023237305A1 (en) 2022-06-09 2023-05-16 Nutritional composition comprising gos and hmos

Publications (1)

Publication Number Publication Date
MX2024013999A true MX2024013999A (es) 2025-01-09

Family

ID=82016420

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024013999A MX2024013999A (es) 2022-06-09 2024-11-12 Composicion nutricional que comprende gos y hmo

Country Status (6)

Country Link
US (1) US20250360151A1 (es)
EP (1) EP4536241A1 (es)
CN (1) CN119300839A (es)
AU (1) AU2023283601A1 (es)
MX (1) MX2024013999A (es)
WO (2) WO2023237306A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025219495A1 (en) * 2024-04-19 2025-10-23 Dsm Ip Assets B.V. A nutritional composition comprising bifidobacterium bifidum r0071 and human milk oligosaccharides
WO2025219496A1 (en) * 2024-04-19 2025-10-23 Dsm Ip Assets B.V. Nutritional composition comprising bifidobacterium longum ssp. infantis r0033 and human milk oligosaccharides
CN120617323A (zh) * 2025-08-15 2025-09-12 东北农业大学 嗜黏蛋白阿克曼菌与母乳低聚糖联用在制备缓解抑郁的产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0481038B1 (en) 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
NL2007268C2 (en) * 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
MX391839B (es) * 2012-12-18 2025-03-19 Abbott Lab Oligosacaridos de leche humana para mejorar sintomas de estres.
CN105518685A (zh) 2013-03-12 2016-04-20 雀巢产品技术援助有限公司 用于为罹患抑郁症的个体选择治疗方案的测定和方法
US10835545B2 (en) 2015-10-28 2020-11-17 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
AU2018265066B2 (en) * 2017-05-09 2023-10-19 Societe Des Produits Nestle S.A. Synergistic production of butyrate associated with the complexity of HMOs blend for use in infants or young children for health purposes
BR112020023102A2 (pt) * 2018-06-25 2021-02-02 Société des Produits Nestlé S.A. uso de oligossacarídeos de leite humano, e composição que compreende os mesmos
US20220079962A1 (en) * 2019-06-04 2022-03-17 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and dietary butyrate

Also Published As

Publication number Publication date
WO2023237305A1 (en) 2023-12-14
EP4536241A1 (en) 2025-04-16
CN119300839A (zh) 2025-01-10
WO2023237306A1 (en) 2023-12-14
AU2023283601A1 (en) 2024-10-31
US20250360151A1 (en) 2025-11-27

Similar Documents

Publication Publication Date Title
MX2024013999A (es) Composicion nutricional que comprende gos y hmo
EP4574158A3 (en) Mixture of hmos and bifidobacteria
PH12022552963A1 (en) Use of human milk oligosaccharides in nutritional compositions for enhancing bone development and/or bone strength
MX2021006178A (es) Una composicion nutricional que comprende una combinacion de oligosacaridos de la leche humana para mejorar la barrera gastrointestinal.
Holan et al. Premature loss of primary anterior teeth due to trauma–potential short‐and long‐term sequelae
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
RU2010123176A (ru) Применение олигосахаридов, содержащих n-ацетиллактозамин, для развития иммунных ответов у новорожденных
RU2017133801A (ru) Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
RU2018107583A (ru) Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
MX350436B (es) Composicion para uso en el aumento de sensibilidad a la insulina y/o la reduccion de resistencia a la insulina.
RU2010123174A (ru) Профилактика и лечение вторичных инфекций после вирусной инфекции
BR112018010505A2 (pt) mistura de oligossacarídeos de leite humano (hmos)
RU2013128595A (ru) Смесь олигосахаридов и продукт питания, содержащий эту смесь, в частности питательная смесь для кормления младенцев
BR0112685A (pt) Composição nutricional
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MX2018008955A (es) Composiciones que comprenden oligosacaridos de la leche humana para usar en infantes o niños pequeños para prevenir o tratar un trastorno de la salud al aumentar la secrecion de glp-1.
RU2017133815A (ru) Композиции для применения в профилактике или лечении отита или бронхита у младенцев или детей младшего возраста
PH12018502382A1 (en) Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
PH12020551822A1 (en) Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
PH12021551071A1 (en) A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function
PH12022551200A1 (en) Compositions comprising human milk oligosaccharides for use in a subject to support language development
Barcellos et al. Prevalence of chewing side preference in the deciduous, mixed and permanent dentitions
RU2019109938A (ru) Питательная композиция для младенцев и/или детей младшего возраста, содержащая олигосахариды
PH12022550887A1 (en) Compositions for use in the reduction of pain and/or perception of pain in infants and young children
MX2023006295A (es) 2'-fucosilactosa para su uso con el fin de estimular la abundancia de f. prausnitzii.